Gordon et al. demonstrated in obese male mice treated with bilirubin nanoparticles, as well as in humanized Gilbert’s syndrome mice with mild hyperbilirubinemia, that phosphorylation and activity of PPARα were significantly higher, and Ucp1 and Adrb3 gene expressions were substantially raised in iWAT [124]. The gene discussed is PPARA; the disease is Gilbert syndrome.